Scott W. Morrison - Jun 13, 2024 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Scott W. Morrison
Stock symbol
CRVS
Transactions as of
Jun 13, 2024
Transactions value $
$0
Form type
4
Date filed
6/17/2024, 04:44 PM
Previous filing
May 31, 2024
Next filing
Jun 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVS Stock Option (Right to Buy) Award $0 +15K $0.00 15K Jun 13, 2024 Common Stock 15K $2.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.